Back to top

Image: Bigstock

Here's What Key Metrics Tell Us About Perrigo (PRGO) Q3 Earnings

Read MoreHide Full Article

Perrigo (PRGO - Free Report) reported $1.04 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 4.1%. EPS of $0.80 for the same period compares to $0.81 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.1 billion, representing a surprise of -4.84%. The company delivered an EPS surprise of +6.67%, with the consensus EPS estimate being $0.75.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Perrigo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Net Sales- Consumer Self-Care International (CSCI): $398 million compared to the $432.27 million average estimate based on two analysts. The reported number represents a change of -4.4% year over year.
  • Net Sales- Consumer Self-Care Americas (CSCA): $646 million versus $664.1 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.8% change.
  • Gross Profit- Consumer Self-Care International- Adjusted (CSCI): $199 million versus $228.07 million estimated by two analysts on average.
  • Gross Profit- Consumer Self-Care Americas- Adjusted (CSCA): $218 million versus $217.28 million estimated by two analysts on average.

View all Key Company Metrics for Perrigo here>>>

Shares of Perrigo have returned -6.9% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Perrigo Company plc (PRGO) - free report >>

Published in